| Date Filed | Type | Description |
| 07/28/2023 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 12,500 shares
@ $0 |
|
| 06/02/2023 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 2,197 shares
@ $0
Disposed/sold 518 options to buy
@ $0
Disposed/sold 259 options to buy
@ $0
Disposed/sold 420 options to buy
@ $0
Disposed/sold 1,000 options to buy
@ $0 |
|
| 06/17/2022 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.36, valued at
$18k
|
|
| 06/10/2022 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.4725, valued at
$9.5k
|
|
| 09/03/2021 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $4.52, valued at
$271.2k
|
|
| 07/19/2021 |
3
| KOVEN ANDREW I (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 06/21/2021 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 06/29/2020 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 28,000 shares
@ $0 |
|
| 06/07/2019 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 21,000 options to buy
@ $5.35, valued at
$112.4k
|
|
| 06/14/2018 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 12,960 options to buy
@ $13.73, valued at
$177.9k
|
|
| 06/06/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2018 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 9,739 shares
@ $1.7, valued at
$16.6k
|
|
| 10/02/2017 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 25,920 options to buy
@ $23.08, valued at
$598.2k
|
|
| 10/02/2017 |
3
| KOVEN ANDREW I (Director) has filed a Form 3 on Kala Pharmaceuticals, Inc. |
| 06/06/2017 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 161,906 shares
@ $1.2792, valued at
$207.1k
|
|
| 05/12/2017 |
4
| KOVEN ANDREW I (President & CBO) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 03/22/2017 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 03/17/2017 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 06/07/2016 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Paid exercise price by delivering 206,070 shares
@ $3.97, valued at
$818.1k
|
|
| 05/13/2016 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Bought 71,500 shares
@ $3.4891, valued at
$249.5k
|
|
| 03/18/2016 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 62,132 shares
@ $0
Granted 52,592 options to buy
@ $3.8, valued at
$199.8k
|
|
| 02/09/2016 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Acquired 1,476,674 shares
@ $0 |
|
| 06/04/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/30/2015 |
4
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Disposed of 38,721 shares
@ $36.53, valued at
$1.4M
Disposed of 125,000 options to buy
@ $20.07, valued at
$2.5M
Disposed of 28,125 options to buy
@ $18.3, valued at
$514.7k
Disposed of 40,600 options to buy
@ $28.3, valued at
$1.1M
|
|
| 11/24/2014 |
4
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Sold 5,308 shares
@ $33.4434, valued at
$177.5k
Sold 134,375 shares
@ $33.4319, valued at
$4.5M
Exercised 125,000 options to buy
@ $20.07, valued at
$2.5M
Exercised 9,375 options to buy
@ $18.3, valued at
$171.6k
|
|
| 03/12/2014 |
4/A
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 15,200 shares
@ $0
Granted 16,300 shares
@ $0 |
|
| 02/28/2014 |
4/A
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 6,375 shares
@ $0 |
|
| 02/20/2014 |
4
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 6,375 shares
@ $0
Paid exercise price by delivering 623 shares
@ $28.3, valued at
$17.6k
Granted 16,300 shares
@ $0
Granted 40,600 options to buy
@ $28.3, valued at
$1.1M
Granted 24,000 options to buy
@ $0 |
|
| 02/11/2014 |
4
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 911 shares
@ $23.68, valued at
$21.6k
|
|
| 06/25/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2013 |
4
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 7,700 shares
@ $0
Granted 15,200 shares
@ $0
Paid exercise price by delivering 910 shares
@ $18.3, valued at
$16.7k
Granted 37,500 options to buy
@ $18.3, valued at
$686.3k
|
|
| 06/25/2012 |
4
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $0 |
|
| 09/20/2011 |
4
| KOVEN ANDREW I (See Remarks) has filed a Form 4 on NEUROLOGIX INC/DE|
Txns:
| Granted 4,946,709 options to buy
@ $0.5, valued at
$2.5M
|
|
|